新产业 (300832)

Shenzhen New Industries Biomedical Engineering Co., Ltd.

ASZ

Tags

300ESG Index300 Non-Cyclical IndexDeepSeekCSI 200 IndexMedical DevicesSTAR and ChiNext 50 IndexGuozheng Growth IndexPrivate Enterprises 100 IndexHigh-Performing StocksNon-Cyclical StocksChiNext InnovationChiNext Large CapChiNext IndexChiNext Blue ChipChiNext HealthcareChiNext TechSZSE 100 IndexSZSE 300 IndexSZSE Growth IndexPharma & BiotechStable Growth IndexConsumer Services IndexSZSE Enterprises Composite IndexGreater Bay Area IndexSZSE Medicine Equal Weight IndexInnovation Demonstration IndexInnovation Engine IndexSZSE 100 Equal Weight IndexZhongchuang Equal Weight IndexShenzhen A-Share Pharmaceutical IndexBOC International CSI 300 ESG IndexChiNext Equal Weight IndexCSI 300 Quality IndexCSI 100 Low Volatility IndexChiNext Composite IndexCSI All-share Pharmaceutical Sector IndexEmerging Technology 100 IndexSZSE Emerging Industries IndexZhongchuang Growth IndexSZSE 1000 IndexSZSE 300 Return IndexCSSW Health IndexCSI 1000 Growth IndexSZSE Component Index ReturnCSI 300 Equal Weight IndexCSI 300 ESG IndexLarge & Mid-cap IndexCSWD Life Sciences IndexShanghai-Hong Kong-Shenzhen 300 IndexCNI 1000 IndexXingyin Wealth Management Balanced 300 IndexCSSW Silk Road IndexCSI Medical IndexExcellent Performance Strategy IndexSZSE Performance IndexChiNext Value IndexAugust 2022 Lock-up ExpiryAntigen Self-testAugust 2021 Lock-up ExpiryCSI 300 Non-cyclical IndexTechnology 50 IndexPension Industry IndexPublic Health IndexSHS Greater Bay Area IndexTechnology 50 Strategy IndexCS High-end Manufacturing IndexAdvanced Manufacturing IndexCSI 300 Shenzhen Market IndexZhongchuang 100 Return IndexSTAR Market & ChiNext 50 IndexSZSE Technology IndexCSI 300 ESG Leading IndexSZSE 100 Return IndexManufacturing IndexChiNext Quality IndexSZSE ChiNext 100 IndexCSI 300 Growth IndexSZSE Pharmaceutical IndexCSI 800 IndexCS Pharmaceutical TI Index100 Performance IndexCSI 300 Preferred IndexCNI Pharmaceutical IndexCSI 1000 Pharmaceutical IndexCNI 300 IndexCCTV 500 IndexCSI 300 USD (CNH) IndexChiNext Basic IndexSZSE Private Enterprises IndexHua Xia Bank ESG IndexCS Pharmaceutical Innovation IndexChina United Quality Growth IndexSZSE Component Pharmaceutical IndexSZSE Low Volatility IndexCSI All-share Pharmaceutical IndexCSI 300 USD IndexSZSE Pharmaceutical 50 IndexSZSE 300 Equal Weight IndexChiNext Low Volatility IndexCSI Pharmaceutical IndexZhaoyang 100 IndexCSI 500 Equal Weight IndexSZSE Component Index Equal WeightCS Biomedicine IndexPharmaceutical & Health 100 IndexCSI 300 Pharmaceutical IndexSME & ChiNext Q IndexCSI 700 IndexMid-small Cap IndexCSI 500 IndexCSI 500 IndexPharmaceutical 50 IndexZhongchuang Low Volatility IndexCSI 500 Growth Innovation IndexPharmaceutical 50 Strategy IndexSZSE 200 Return IndexSZSE 200 IndexChiNext Manufacturing IndexChiNext Growth IndexESG 300 IndexCR New Momentum IndexOrient Securities Competition IndexChiNext Return IndexJuchao Mid-cap IndexShenzhen Technology IndexSZSE 500 IndexChiNext Emerging IndexCSI 300 Growth Innovation IndexCSI 500 ESG IndexChiNext Growth IndexPerformance IndexGuangdong

K-Line Chart

No K-line data

Company NameShenzhen New Industries Biomedical Engineering Co., Ltd.
Listing Date2020-05-12
Issue Price31.39Yuan
Registered Capital78571.878510K Yuan
Legal RepresentativeRao Wei
Registered Address21st Floor, New Industries Biomedical Building, No. 23 Jinxiu East Road, Jinsha Community, Kengzi Street, Pingshan District, Shenzhen City, Guangdong Province
IndustryMedical Devices
Main BusinessResearch, development, production, and sales of a series of fully automated chemiluminescence immunoassay analyzers and supporting reagents.
Company ProfileThe predecessor of Shenzhen New Industries Biomedical Engineering Co., Ltd. was Shenzhen New Industries Biomedical Engineering Co., Ltd., established on December 15, 1995. On August 23, 2012, Shenzhen New Industries Biomedical Engineering Co., Ltd. was wholly transformed into Shenzhen New Industries Biomedical Engineering Co., Ltd.

Stock Details

1. Key Indicators

  • Total Shares(W): 78571.88
  • Circulating A-Shares(W): 68199.74
  • Earnings Per Share(RMB): 1.5334
  • Net Assets Per Share(RMB): 11.1297
  • Operating Revenue(W RMB): 342761.96
  • Total Profit(W RMB): 136664.73
  • Net Profit Attributable to Parent(W RMB): 120480.26
  • Net Profit Growth Rate(%): -12.92
  • Weighted Return on Equity(%): 13.8100
  • Operating Cash Flow Per Share(RMB): 1.3540
  • Undistributed Profit Per Share(RMB): 7.9002
  • Capital Reserve Per Share(RMB): 1.6957

2. Main Business

The main business covers:

  • Research, production, sales and customer service of products in the in-vitro diagnostics field

3. Company Basic Information

  • Company Name: Shenzhen New Industries Biomedical Engineering Co., Ltd.
  • Listing Date: 2020-05-12
  • Industry: Pharmaceutical Manufacturing
  • Address: New Industries Biomedical Building, No. 23 Jinxiu East Road, Jinsha Community, Kengzi Street, Pingshan District, Shenzhen City, Guangdong Province
  • Website: www.snibe.com
  • Company Profile: On November 13, 1995, Shenzhen Fair Accounting Firm verified the capital contribution at the establishment of New Industries Co., Ltd. and issued the "Capital Verification Report" (Shenghuiyanzi [1995] No. 161). On December 15, 1995, New Industries Co., Ltd. obtained the "Business License" issued by the Shenzhen Administration for Industry and Commerce. On August 17, 2012, the company held a shareholders' meeting and passed a resolution to convert the entire company into a joint-stock company based on the audited net asset value of RMB 162,976,369.76 as of May 31, 2012, at a ratio of 1.6298:1. The total share capital of the joint-stock company was 100 million shares, and the portion exceeding the registered capital at the time of conversion, RMB 62,976,369.76, was recorded as capital reserve of the joint-stock company. All shareholders of the company contributed their corresponding share of the net assets of the company's equity at a ratio of 1.6298:1 to become the promoters' shares of the joint-stock company. On August 23, 2012, upon approval by the Shenzhen Market Supervision Administration, the joint-stock company obtained the amended "Business License".

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Tibet New Industries Investment Management Co., Ltd. General Legal Person 21117.74 30.96
2 Tianjin Hongshan Juye Equity Investment Partnership (Limited Partnership) General Legal Person 8345.41 12.24
3 Hong Kong Securities Clearing Company Ltd. Northbound Funds 2648.24 3.88
4 National Social Security Fund 503 Portfolio Social Security Fund 1700.01 2.49
5 HuaBao CSI Medical ETF Fund 1109.91 1.63
6 E Fund Blue Chip Select Hybrid Securities Investment Fund Fund 1100.01 1.61
7 Shanghai Zhancheng Investment Management Co., Ltd. - Zhancheng Darwin Flagship Private Fund General Legal Person 868.00 1.27
8 E Fund ChiNext ETF Fund 710.69 1.04
9 Fullgoal Consumption Theme Hybrid Securities Investment Fund Class A Fund 326.21 0.48
10 Fullgoal Value Creation Hybrid Securities Investment Fund Class A Fund 251.99 0.37

5. Concept Sectors

  • Hepatitis Concept
  • DeepSeek
  • Margin Trading & Securities Lending
  • High-Performance Stock
  • Social Security Fund Heavy Holdings
  • Non-Cyclical Stock
  • Zhongchuang 100
  • ChiNext Index
  • Mid-Cap Growth
  • SZSE 100
  • SZSE 300
  • Technology 100
  • Private Enterprise 100
  • SZSE Growth
  • SZSE Growth Index
  • CSI 300
  • ChiNext 300
  • CSI 200
  • CSI 300 Non-Cyclical
  • SZSE Innovation
  • ChiNext Innovation
  • ChiNext Blue Chip
  • ChiNext Large Cap
  • ChiNext Quality
  • ChiNext Technology
  • ChiNext Pharmaceutical
  • STAR Market and ChiNext 50
  • Innovation 100
  • CSI 300 ESG
  • Pearl River Delta

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information